deltatrials
Active Not Recruiting PHASE4 INTERVENTIONAL 1-arm NCT03023631

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Human Papillomavirus Antibody Response After GARDASIL 9 Vaccination in Patients After Allogeneic Stem Cell Transplantation

Sponsor: M.D. Anderson Cancer Center

Conditions Allogeneic Hematopoietic Stem Cell Transplant Recipient Hematopoietic and Lymphoid Cell Neoplasm
Interventions Recombinant Human Papillomavirus Nonavalent Vaccine
Updated 22 times since 2017 Last updated: Nov 17, 2025 Started: Apr 23, 2017 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Allogeneic Hematopoietic Stem Cell Transplant Recipient and Hematopoietic and Lymphoid Cell Neoplasm and is currently ongoing. M.D. Anderson Cancer Center leads this study, which shows 22 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~May 2017 · 30 days · monthly snapshot~May 2017 – ~Jun 2018 · 13 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Dec 2018 · 5 months · monthly snapshot~Dec 2018 – ~Jul 2019 · 7 months · monthly snapshot~Jul 2019 – ~Apr 2020 · 9 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshot~Jul 2022 – ~Aug 2023 · 13 months · monthly snapshot~Aug 2023 – ~Dec 2023 · 4 months · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~May 2024 · 4 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~May 2025 · 6 months · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Dec 2025 · 6 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshot

Change History

22 versions recorded

  1. Dec 2025 — Present [monthly]

    Active Not Recruiting PHASE4

  2. Jun 2025 — Dec 2025 [monthly]

    Active Not Recruiting PHASE4

  3. May 2025 — Jun 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Nov 2024 — May 2025 [monthly]

    Active Not Recruiting PHASE4

  5. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE4

▶ Show 17 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  2. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

  3. Jan 2024 — May 2024 [monthly]

    Active Not Recruiting PHASE4

  4. Dec 2023 — Jan 2024 [monthly]

    Active Not Recruiting PHASE4

  5. Aug 2023 — Dec 2023 [monthly]

    Active Not Recruiting PHASE4

  6. Jul 2022 — Aug 2023 [monthly]

    Active Not Recruiting PHASE4

  7. Dec 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE4

  8. Apr 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  9. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  10. Apr 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  11. Jul 2019 — Apr 2020 [monthly]

    Recruiting PHASE4

  12. Dec 2018 — Jul 2019 [monthly]

    Recruiting PHASE4

  13. Jul 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  14. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE4

  15. May 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  16. Apr 2017 — May 2017 [monthly]

    Not Yet Recruiting PHASE4

  17. Feb 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations